Lilly and JDRF Fund Research for Type 1 Diabetes
Lilly and JDRF (Juvenile Diabetes Research Foundation) have funded a new research study in regenerative medicine for type 1 diabetes. They have provided the funds to stat early stage research that could potentially lead to a regenerating insulin process and allow type 1 diabetes to regenerate the cells that produce insulin in the body.
Regenerative medicine, a new frontier in science that replaces or regenerates new cells, tissues or organs, and while this particular research is in the early stage, it may ultimately lead to new approaches to treating people with type 1 diabetes." In some cases, it may be the cure for type 1 diabetes. However, that is most likely several years in the future.
One of the options for the research is by triggering the body to grow its own new beta cells, either by growing existing ones Even if a person has had diabetes for years the body still has some active cells. Diabetes results when there are not enough active cells to produce the hormone insulin.
The other option for research is to create new cells and reprogram them by changing (converting) on cell in the body to another type of cell. Both options have strong tendencies for development and most important to work and eliminate the need for insulin.